Skip to content

Intellia Therapeutics

US · NTLA #2899 by market cap Listed 2016
10.00 +0.48 +5.04%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:01

Quant vs Street three independent views, side by side

StockVane factor grade
C-
Momentum strategy signal
Sell
Analyst consensus
Hold

Mostly aligned, one view stands apart.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

✦ Quant Analyst Revision Trend how this is computed

Deteriorating
3 6
■ Upgrades■ Downgrades
  • 3 upgrades vs 6 downgrades among tracked analyst rating changes.
  • Most recent: Barclays moved from Buy to Sell on 2026-10-06.

Analyst consensus 11 analysts

Hold
Avg price target 19.20 +92.0%
Price target rangecurrent 10.00
Low8.00
Avg19.20
High49.00
Buy 36% Hold 45% Sell 18%
Recent ratings (25)
DateFirmAnalystRatingTarget
2026-11-13 BofA Securities -- Hold 16.00
2026-11-13 H.C. Wainwright -- Buy 25.00
2026-11-09 CCORF -- Buy 49.00
2026-11-09 J.P. Morgan -- Sell 9.00
2026-11-06 JonesTrading -- Buy 27.00
2026-11-06 BofA Securities -- Hold 16.00
2026-11-06 Wedbush -- Hold 13.00
2026-11-06 Morgan Stanley -- Hold 15.00
2026-11-06 H.C. Wainwright -- Buy 25.00
2026-11-05 H.C. Wainwright -- Buy 25.00
2026-11-05 RBC Capital -- Hold 15.00
2026-10-15 Wells Fargo -- Hold 15.00
2026-10-07 Barclays -- Sell 8.00
2026-10-06 Barclays -- Sell 8.00
2026-09-09 Wedbush -- Hold 13.00
2026-09-09 H.C. Wainwright -- Buy 25.00
2026-09-04 TD Cowen -- Buy --
2026-08-14 JonesTrading -- Buy 29.00
2026-08-10 Morgan Stanley -- Hold 15.00
2026-08-07 BofA Securities -- Hold 17.00
2026-08-07 Evercore -- Buy 24.00
2026-08-07 H.C. Wainwright -- Buy 25.00
2026-08-06 CCORF -- Buy 49.00
2026-08-06 William Blair -- Buy --
2026-08-06 Evercore -- Buy 24.00

Price target trend monthly average, last 3 years

Recent rating changes

DateFirmChangeTarget
2026-10-06 Barclays Buy → Sell 8.00
2026-08-06 Evercore Hold → Buy 24.00
2026-07-15 Wolfe Research Hold → Sell 9.00
2026-04-28 Evercore Buy → Hold 16.00
2026-03-04 JonesTrading Hold → Buy 29.00
2026-03-02 William Blair Hold → Buy --
2025-11-11 JonesTrading Buy → Hold --
2025-11-07 J.P. Morgan Hold → Sell 5.00
2025-10-31 BofA Securities Buy → Hold 14.00

Earnings history price reaction on the day

PeriodReport dateSessionOptions expectedActual move
2026/Q2 2026-08-06 -- ±11.82% +2.46% (in line)
2025/Q4 2026-02-26 -- ±17.42% +6.41% (in line)
2025/Q2 2025-08-07 -- ±20.15% +0.79% (in line)
2025/Q1 2025-05-08 -- ±21.04% +13.58% (in line)
2024/Q4 2025-02-27 -- ±23.48% +0.56% (in line)
2024/Q3 2024-11-07 -- ±13.59% -0.37% (in line)
2024/Q2 2024-08-08 -- ±19.43% +5.02% (in line)
2024/Q1 2024-05-09 -- ±15.08% +8.09% (in line)
2023/Q4 2024-02-22 -- ±19.29% +1.12% (in line)
2023/Q3 2023-11-09 -- ±13.81% -12.27% (in line)
2023/Q2 2023-08-03 -- ±15.20% -1.56% (in line)
2023/Q1 2023-05-04 -- ±15.25% +13.14% (in line)

"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.

Quote time 2026-11-20 20:01:29 · For reference only, not investment advice and not tailored to your situation.

Intellia Therapeutics discussion 0 comments

Add a comment